Endocrine Abstracts

Introduction: The RECOVERY trial2 reported patients with Covid-19 receiving requiring invasive mechanical ventilation or oxygen that the use of dexamethasone (6 mg for 10 days) resulted in lower 28-day mortality. Adrenal insufficiency (AI) from hypothalamic-pituitary-adrenal (HPA) axis suppression3 is a serious, potentially life-threatening side effect of glucocorticoids treatment.Objective: We aimed to investigate the effects of Co...

IntroductionWe are currently mid Covid-19 pandemic. In the last year there have been 116, 135, 492 confirmed Covid-19 cases worldwide, with an estimated 2, 581, 976 deaths.The RECOVERY trial reported for patients hospitalized with Covid-19, the use of dexamethasone (6 mg for 10 days) resulted in lower 28-day mortality among those who were receiving either invasive mechanical ventilation or oxygen alone at randomisation. Adrenal ins...